These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 8560161)
1. Intranasal immunotherapy with Dermatophagoides extract: in vivo and in vitro results of a double-blind placebo-controlled trial. Fanales-Belasio E; Ciofalo A; Zambetti G; Ansotegui IJ; Scala E; Paganelli R; Filiaci F Rhinology; 1995 Sep; 33(3):126-31. PubMed ID: 8560161 [TBL] [Abstract][Full Text] [Related]
2. The effect of local nasal immunotherapy in allergic rhinitis: using strips of the allergen dermatophagoides pteronyssinus. Tsai JJ; Liao EC; Tsai FH; Hsieh CC; Lee MF J Asthma; 2009 Mar; 46(2):165-70. PubMed ID: 19253124 [TBL] [Abstract][Full Text] [Related]
3. Low-dose local nasal immunotherapy in children with perennial allergic rhinitis due to Dermatophagoides. Marcucci F; Sensi LG; Caffarelli C; Cavagni G; Bernardini R; Tiri A; Riva G; Novembre E Allergy; 2002 Jan; 57(1):23-8. PubMed ID: 11991284 [TBL] [Abstract][Full Text] [Related]
4. Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy. Marcucci F; Sensi L; Di Cara G; Salvatori S; Bernini M; Pecora S; Burastero SE Pediatr Allergy Immunol; 2005 Sep; 16(6):519-26. PubMed ID: 16176400 [TBL] [Abstract][Full Text] [Related]
5. Topical nasal immunotherapy. Immunologic response of IgE in nasal secretion after immunotherapy with Dermatophagoides pteronyssinus. Martín Mateos MA; Monferrer R; Muñoz López F Allergol Immunopathol (Madr); 1990; 18(4):223-8. PubMed ID: 2264553 [TBL] [Abstract][Full Text] [Related]
6. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study. Rimmer J; Peake HL; Santos CM; Lean M; Bardin P; Robson R; Haumann B; Loehrer F; Handel ML Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036 [TBL] [Abstract][Full Text] [Related]
7. Nasal immunotherapy in weed-induced allergic rhinitis. Gaglani B; Borish L; Bartelson BL; Buchmeier A; Keller L; Nelson HS Ann Allergy Asthma Immunol; 1997 Sep; 79(3):259-65. PubMed ID: 9305235 [TBL] [Abstract][Full Text] [Related]
8. Humoral response to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus. Piazza I; Bizzaro N Ann Allergy; 1993 Nov; 71(5):461-9. PubMed ID: 7755664 [TBL] [Abstract][Full Text] [Related]
10. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children. Altintaş D; Akmanlar N; Güneşer S; Burgut R; Yilmaz M; Buğdayci R; Aksungur P Allergol Immunopathol (Madr); 1999; 27(6):309-17. PubMed ID: 10611556 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Tari MG; Mancino M; Monti G Allergol Immunopathol (Madr); 1990; 18(5):277-84. PubMed ID: 2097894 [TBL] [Abstract][Full Text] [Related]
12. Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients. Ferreira MB; Santos AS; Santos MC; Carlos ML; Barbosa MA; Carlos AG Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):96-102. PubMed ID: 15918296 [TBL] [Abstract][Full Text] [Related]
13. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma. Ameal A; Vega-Chicote JM; Fernández S; Miranda A; Carmona MJ; Rondón MC; Reina E; García-González JJ Allergy; 2005 Sep; 60(9):1178-83. PubMed ID: 16076305 [TBL] [Abstract][Full Text] [Related]
14. Local conjunctival immunotherapy: the effect of dermatophagoides pteronyssinus local conjunctival immunotherapy on conjunctival provocation test in patients with allergic conjunctivitis. Núñez JA; Cuesta U Allergol Immunopathol (Madr); 2000; 28(6):301-6. PubMed ID: 11269896 [TBL] [Abstract][Full Text] [Related]
15. Immunologic evaluation of 24 month course of sublingual immunotherapy. Tari MG; Mancino M; Madonna F; Buzzoni L; Parmiani S Allergol Immunopathol (Madr); 1994; 22(5):209-16. PubMed ID: 7840022 [TBL] [Abstract][Full Text] [Related]
16. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy. Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829 [TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial. Varney VA; Edwards J; Tabbah K; Brewster H; Mavroleon G; Frew AJ Clin Exp Allergy; 1997 Aug; 27(8):860-7. PubMed ID: 9291281 [TBL] [Abstract][Full Text] [Related]
18. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study]. Silny W; Czarnecka-Operacz M Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298 [TBL] [Abstract][Full Text] [Related]
19. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study. Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685 [TBL] [Abstract][Full Text] [Related]
20. Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial. Wang DH; Chen L; Cheng L; Li KN; Yuan H; Lu JH; Li H Laryngoscope; 2013 Jun; 123(6):1334-40. PubMed ID: 23616386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]